The SA Journal Diabetes & Vascular Disease Vol 12 No 2 (December 2015)

2 / 48

Dyna Indapamide SR. Each sustained release tablet contains 1,5 mg indapamide. Reg. No.: RSA S3 42/7.1/0790. NAM NS2 12/7.1/0138. For full prescribing information, refer to the package insert approved by the
Medicines Control Council, 25 November 2011. 1) Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drug Safety 2001;24(15):1155-1165. 2) Department of Health website.
– Accessed 28/04/2015. DINC110/05/2015.
For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966
Tel 021 707 7000 Fax 021 701 5898 Email CUSTOMER CARE LINE 0860 PHARMA (742 762)
SUSTAINED RELEASE
METABOLICALLY NEUTRAL 1
A Lupin Group Company